Fondation Francqui-Stichting
Fondation d’Utilité Publique -  Stichting van Openbaar Nut

Programme

Saturday March 6th, 2004

8.30 : Welcome Mark Eyskens, Chairman of the Francqui Foundation, Minister of State
8.50 : General Introduction & Welcome Professor Peter Carmeliet, Katholieke Universiteit Leuven-Belgium

Session-Chairman : Professor Marc Tessier-Lavigne, Genentech’s Research Department, Genentech, Inc, San Francisco-USA

9.00 – 9.30 Professor Andrew Wurmser, The Salk Institute, Laboratory of Genetics, La Jolla, San Diego-USA - Neural stem cells and neurodegeneration
9.30-10.00 Professor Steven Goldman, University of Rochester Medical Center, Department of Neurology, New York-USA - Establishing permissive environments neurogenesis in the adult brain
10.00-10.30 Professor Theo Palmer, Stanford University, Departments of Neurosurgery and Neurology - USA - Vascular niche & neural stem cells

10.30-11.00 Coffee

Session-Chairman : Professor Peter Carmeliet, Katholieke Universiteit Leuven-Belgium

11.00-11.30 Professor Takayuki Asahara, Kobe Institute of Biomedical Research and Innovation/RIKEN Center of Developmental Biology, Kobe-Japan - VEGF, endothelial and neural stem cells
11.30-12.00 Professor Karl Plate, Institute of Neurology, Edinger Institute, Joghann-Wolgang Goethe University, Frankfurt-Germany - VEGF treatment to stimulate neurogenesis

12.15-13.30 Lunch

Session-Chairman : Professor Matthew During, University of Auckland, Faculty of Medical and Health Sciences, Department of Molecular Medicine & Pathology, Auckland-New Zealand

13.45-14.15 Professor Olle Lindvall, Section of Restorative Neurology, Wallenberg Neuroscience Center, Lund-Sweden - Neurogenesis after ischemic and epileptic insults
14.15-14.45 Professor David Greenberg, Buck Institute for Age Research - Novato-USA - VEGF in neurogenesis, neuroprotection and stroke
14.45-15.15 Professor Andreas Pueschel, Institut für Allgemeine Zoologie und Genetik, Westfälische Wilhems-Universität, Munster-Germany -  Semaphorin-3A & plexins in axon guidance

15.15-15.45 Coffee

Session-Chairman : Professor David Greenberg, Buck Institute for Age Research - Novato-USA

15.45-16.15 Professor Frederico Bussolino, University of Torino, Institute for Cancer Research and Treatment, Candiolo-Italy - Semaphorin-3A in vessel patterning
16.15-16.45 Professor Marc Tessier-Lavigne, Genentech’s Research Department, Genentech, Inc, San Francisco-USA - Genetics of neuronal axon guidance
16.45-17.15 Professor Alex Kolodkin, The Johns Hopkins School of Medicine, Departement of Neuroscience, Baltimore-USA - semaphorin & VEGF in neurà-vascular development

* * *

Sunday March 7th, 2004

Session-Chairman : Professor Takayuki Asahara, Kobe Institute of Biomedical Research and Innovation/RIKEN Center of Developmental Biology, Kobe-Japan

8.45-9.15 Professor Peter Carmeliet, Katholieke Universiteit Leuven, Belgium): VEGF in ALS
9.15-9.45 Professor Raj Kalaria, Institute for Ageing and Health, CBV Group, Wolfson Research Centre, Newcastle General Hospital, UK - Alzheimer’s disease

9.45-10.15 Coffee

Session-Chairman : Professor Karl Plate, Institute of Neurology, Edinger Institute, Joghann-Wolgang Goethe University, Frankfurt-Germany

10.15-10.45 Professor Matthew During, University of Auckland, Faculty of Medical and Health Sciences, Department of Molecular Medicine & Pathology, Auckland-New Zealand - Gene therapy for CNS disorders
10.45-11.15 Professor Gianvito Martino, Neuroimmunology Unit, Dept. Of Neuroscience, Dibit, San Raffaele Scientific Institute, Milan-Italy - Neural stem cells for treatment of MS
11.15-11.45 Professor Christer Betsholtz, Department of Medical Biochemistry, University of Goteborg-Sweden - Genetics of endothelial growth cone guidance

11.45-12.00 Thank you and farewell

12.00- PM Lunch and departure